Page last updated: 2024-11-03

ro 31-8220 and Glioblastoma

ro 31-8220 has been researched along with Glioblastoma in 2 studies

Ro 31-8220: a protein kinase C inhibitor

Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, L1
Yu, J1
Pan, H1
Hu, P1
Hao, Y1
Cai, W1
Zhu, H1
Yu, AD1
Xie, X1
Ma, D1
Yuan, J1
Shen, L1
Glazer, RI1

Other Studies

2 other studies available for ro 31-8220 and Glioblastoma

ArticleYear
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Nov-27, Volume: 104, Issue:48

    Topics: Autophagy; Calcium Channel Blockers; Cell Line, Tumor; Drug Evaluation, Preclinical; Fluspirilene; G

2007
Induction of apoptosis in glioblastoma cells by inhibition of protein kinase C and its association with the rapid accumulation of p53 and induction of the insulin-like growth factor-1-binding protein-3.
    Biochemical pharmacology, 1998, May-15, Volume: 55, Issue:10

    Topics: Apoptosis; Brain Neoplasms; Cell Nucleus; DNA Fragmentation; Enzyme Inhibitors; Flow Cytometry; Gene

1998